International Immunopharmacology

International Immunopharmacology - ISSN 1567-5769
Source Normalized Impact per Paper (SNIP): 0.935 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 0.941 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.551 (2015) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Thomson Reuters Journal Citation Reports 2015
5 Year Impact Factor: 2.752 (2015) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2014 to the previous five years and divided by the source items published in the previous five years.
© Journal Citation Reports 2015, Published by Thomson Reuters
Volumes: Volumes 42-53
Issues: 12 issues
ISSN: 15675769

Personal Subscription

Tax/VAT will be calculated at check-out

Shop With Confidence

  • Free Shipping around the world
  • Broad range of products

Description

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

• Agents that activate genes or modify transcription and translation within the immune response.

• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

• Production, function and regulation of cytokines and their receptors.

• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

• Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system. • Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses.

• The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc.

• The Editors will be pleased to receive published books for possible independent review.

Please Bookmark this URL: http://www.elsevier.com/locate/intimp

These Backfiles include Immunopharmacology and the International Journal of Immunopharmacology.